An idea that has propelled Alzheimer’s research for more than 30 years is approaching its day of reckoning. Scientists are launching a study designed to make or break the hypothesis that Alzheimer’s is caused by a sticky substance called beta-amyloid. The study will give an experimental anti-amyloid drug to people as young as 18 who […]
Washington University School of Medicine in St. Louis is launching an international clinical trial aimed at preventing Alzheimer’s disease in people genetically destined to develop the illness at a young age. Unlike most other Alzheimer’s prevention trials, this one will enroll people before the disease has taken hold – up to 25 years before the […]
At the Washington University in St. Louis Board of Trustees meeting March 6, several faculty members were appointed, promoted or granted tenure, effective July 1 unless otherwise indicated. Appointment with tenure Stephanie Li as professor of English in Arts & Sciences; Alessandro Vindigni as professor of medicine, of pathology and immunology, and of biochemistry and molecular biophysics at […]
After some costly and disappointing drug trial failures, the field welcomes a funding surge, tools for tracking disease, and interdisciplinary collaborations to tackle one of science’s most stubborn puzzles. In the last five years, as several large clinical trials testing drugs for Alzheimer’s disease failed, the field came to a stark conclusion: These approaches did […]
